Dimitri P. Mikhailidis - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Dimitri P. Mikhailidis's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Dimitri P. Mikhailidis

Dimitri P. Mikhailidis

Verified

Editor-in-Chief, Clinical Lipidology

United Kingdom

Final Covers

Climate Change , Health , Energy Transition

Doesn’t Cover

I have not ever written a sports story.

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 32

  • Editorial: from albuminuria to uric acid - emerging risk factors beyond lipids

    By Mikhailidis DP, Debabrata Mukherjee, Dimitri P. Mikhailidis| ncbi.nlm.nih.gov@ Would you like email updates of new search results? Send even when there aren't any new results

    By Mikhailidis DP, Debabrata Mukherjee, Dimitri P. Mikhailidis · ncbi.nlm.nih.gov

    Jun. 02, 2023

  • Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!

    By Mikhailidis DP, Niki Katsiki, Manfredi Rizzo, Dimitri P. Mikhailidis| ncbi.nlm.nih.gov@ Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

    By Mikhailidis DP, Niki Katsiki, Manfredi Rizzo, Dimitri P. Mikhailidis · ncbi.nlm.nih.gov

    May. 27, 2023

  • Editorial: from albuminuria to uric acid - emerging risk factors beyond lipids

    By Mikhailidis DP, Debabrata Mukherjee, Dimitri P. Mikhailidis| ncbi.nlm.nih.gov@ Would you like email updates of new search results? Send even when there aren't any new results

    By Mikhailidis DP, Debabrata Mukherjee, Dimitri P. Mikhailidis · ncbi.nlm.nih.gov

    Jun. 02, 2023

As seen in

Company Info

Clinical Lipidology